These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 6803666)

  • 1. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant.
    Angus BL; Carey AM; Caron DA; Kropinski AM; Hancock RE
    Antimicrob Agents Chemother; 1982 Feb; 21(2):299-309. PubMed ID: 6803666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant.
    Nicas TI; Hancock RE
    J Bacteriol; 1983 Jan; 153(1):281-5. PubMed ID: 6294050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and chromatographic analysis of lipopolysaccharide from an antibiotic-supersusceptible mutant of Pseudomonas aeruginosa.
    Kropinski AM; Kuzio J; Angus BL; Hancock RE
    Antimicrob Agents Chemother; 1982 Feb; 21(2):310-9. PubMed ID: 6803667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in Efflux (
    Shen X; Johnson NV; Kreamer NNK; Barnes SW; Walker JR; Woods AL; Six DA; Dean CR
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31036686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of porin and beta-lactamase in beta-lactam resistance of Pseudomonas aeruginosa.
    Hancock RE; Woodruff WA
    Rev Infect Dis; 1988; 10(4):770-5. PubMed ID: 2460909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.
    Piddock LJ; Hall MC; Bellido F; Bains M; Hancock RE
    Antimicrob Agents Chemother; 1992 May; 36(5):1057-61. PubMed ID: 1510393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.
    Li XZ; Ma D; Livermore DM; Nikaido H
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1742-52. PubMed ID: 7986004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Hirai K; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):582-6. PubMed ID: 3111356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.
    Li XZ; Livermore DM; Nikaido H
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1732-41. PubMed ID: 7986003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of Pseudomonas aeruginosa to beta-lactam antibiotics.
    Soto UL; Amador SM; Ramos FJ; Baca BE
    Folia Microbiol (Praha); 1987; 32(4):290-6. PubMed ID: 3117650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.
    Godfrey AJ; Bryan LE
    Antimicrob Agents Chemother; 1984 Oct; 26(4):485-8. PubMed ID: 6440472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.
    Pagani L; Landini P; Luzzaro F; Debiaggi M; Romero E
    Microbiologica; 1990 Jan; 13(1):43-53. PubMed ID: 2155376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa: evidence for the involvement of lipopolysaccharide in determining outer membrane permeability to carbenicillin and gentamicin.
    Shearer BG; Legakis NJ
    J Infect Dis; 1985 Aug; 152(2):351-5. PubMed ID: 3928770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outer membrane permeability and beta-lactamase content in Pseudomonas maltophilia clinical isolates and laboratory mutants.
    Mett H; Rosta S; Schacher B; Frei R
    Rev Infect Dis; 1988; 10(4):765-9. PubMed ID: 3263685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.
    Aronoff SC
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1636-9. PubMed ID: 2855296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC
    Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of 4-amino-4-deoxy-arabinose in LPS of supersusceptible strain Pseudomonas aeruginosa Z61: noncorrelation with polymyxin resistance.
    Conrad RS; Boll M; Radziejewska-Lebrecht J; Galanos C
    Curr Microbiol; 1999 Apr; 38(4):228-32. PubMed ID: 10069859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of beta-lactamases and outer membrane proteins in multiple beta-lactam resistance of Enterobacter cloacae.
    Werner V; Sanders CC; Sanders WE; Goering RV
    Antimicrob Agents Chemother; 1985 Apr; 27(4):455-9. PubMed ID: 3873897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors involved in beta-lactam antibiotic resistance in Pseudomonas aeruginosa.
    Ohmori H; Azuma A; Suzuki Y; Hashimoto Y
    Antimicrob Agents Chemother; 1977 Oct; 12(4):537-9. PubMed ID: 411418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.